DOI: 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

Issue 07 · Volume 120 · July 2012 DOI: 10.1055/s-002-23461

Article

383
Flemming, G.M. C.; Petzold, S.; Meigen, C.; Körner, A.; Kiess, W.; Kratzsch, J.: Is Circulating Osteocalcin Related to Adipokines and Overweight/Obesity in Children and Adolescents?
388
Yin, G.; Zhang, S.; Yan, L.; Wu, M.; Xu, M.; Li, F.; Cheng, H.: One-hour Upright Posture is an Ideal Position for Serum Aldosterone Concentration and Plasma Renin Activity Measuring on Primary Aldosteronism Screening
395
Tekcan, D.; Baş, F.; Atalar, F.; Aydın, B. K.; Akan, G.; Tarhan, T.; Bundak, R.; Darendeliler, F.: No Effect of the IGF-1 Gene rs35767 and rs17032362 Polymorphisms in the Etiology of Idiopathic Short Stature
401
Suk, J. H.; Lee, J. H.; Kim, J. M.: Association between Thyroid Autoimmunity and Fibromyalgia
405
Steinbach, S.; Hundt, W.; Hamann, K. F.; Werner, J. A.; Mandic, R.: Effect of Thirst Challenge on ADH Levels in Patients with Bilateral Menière’s Disease
410
Hoffmann, F.; Icks, A.: Diabetes ‘Epidemic’ in Germany? A Critical Look at Health Insurance Data Sources
416
Raptis, A. E.; Bacharaki, D.; Mazioti, M.; Marathias, K. P.; Markakis, K. P.; Raptis, S. A.; Dimitriadis, G. D.; Vlahakos, D. V.: Anemia due to Coadministration of Renin-Angiotensin-System Inhibitors and PPARγ Agonists in Uncomplicated Diabetic Patients
420
Heald, A. H.; Narayanan, R. P.; Lowes, D.; Jarman, E.; Onyekwelu, E.; Qureshi, Z.; Laing, I.; Anderson, S. G.: HOMA-S is Associated with Greater HbA1c Reduction with a GLP-1 Analogue in Patients with Type 2 Diabetes
424
Dogan, S. M.; Aktop, Z.; Aydin, M.; Karabag, T.; Sayin, M. R.; Bilici, H. M.; Atmaca, H.: Effects of Impaired Fasting Glucose on Aortic Elasticity
428
Rogowicz-Frontczak, A.; Zozulińska-Ziółkiewicz, D.; Niedźwiecki, P.; Litwinowicz, M.; Wierusz-Wysocka, B.: Does Glucagon Stimulation Test Help to Predict Autoimmunity in Newly Diagnosed Non Obese Adults with Diabetes?

Short Communication

435
Schütt, M.; Schmidt, T.; Schwaab, B.: Cardio-metabolic Characterisation of Patients with Coronary Heart Disease: Specific Consideration of the 1-h Postprandial Plasma Glucose